Buruli ulcer and mycolactone-producing mycobacteria.

Area of Science:

• Infectious Diseases
• Microbiology
• Genetics

Background:

• Buruli ulcer (BU) is an emerging infectious disease caused by Mycobacterium ulcerans.
• Primarily endemic in sub-Saharan Africa, BU cases are reported globally, including in Japan and China with a proposed subspecies, M. ulcerans subsp. shinshuense.
• Mycobacterium ulcerans is classified as nontuberculous mycobacteria but exhibits unique pathogenic characteristics.

Purpose of the Study:

• To highlight the unique characteristics of Mycobacterium ulcerans.
• To emphasize the role of its virulent plasmid in pathogenesis.
• To discuss the implications of plasmid-toxin linkage in mycobacterial diseases.

Main Methods:

• Literature review and synthesis of existing data on Buruli ulcer and Mycobacterium ulcerans.
• Analysis of the genetic makeup of M. ulcerans, focusing on its plasmid.
• Comparative analysis with other human disease-causing mycobacteria.

Main Results:

• Mycobacterium ulcerans possesses a unique 174-kbp virulent plasmid.
• This plasmid encodes polyketide synthase, responsible for producing the macrolide toxin mycolactone.
• This plasmid-pathogenesis linkage is a distinctive feature not observed in other pathogenic mycobacteria.

Conclusions:

• The giant virulent plasmid and its mycolactone toxin production are key to Mycobacterium ulcerans pathogenesis.
• Understanding this unique genetic mechanism is crucial for Buruli ulcer research and treatment.
• This finding differentiates M. ulcerans from other mycobacteria, offering insights into novel therapeutic targets.